Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer
It is estimated that early detection of pancreatic ductal adenocarcinoma (PDAC) could increase long-term patient survival by as much as 30% to 40% (Seufferlein, T. et al., Nat. Rev. Gastroenterol. Hepatol. 2016, 13, 74–75). There is an unmet need for reagents that can reliably identify ear...
Main Authors: | Gail L. Matters, John F. Harms |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9059/6/2/65 |
Similar Items
-
CCK‐1 and CCK‐2 receptor agonism do not stimulate GLP‐1 and neurotensin secretion in the isolated perfused rat small intestine or GLP‐1 and PYY secretion in the rat colon
by: Ida M. Modvig, et al.
Published: (2020-01-01) -
Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
by: Truc T. Huynh, et al.
Published: (2022-06-01) -
Distribution of cionin, a cholecystokinin/gastrin family peptide, and its receptor in the central nervous system of Ciona intestinalis type A
by: Shiho Taniguchi, et al.
Published: (2024-03-01) -
Inhibition of Gastrin-Releasing Peptide Attenuates Phosphate-Induced Vascular Calcification
by: Hyun-Joo Park, et al.
Published: (2020-03-01) -
Bimodal MRI/Fluorescence Nanoparticle Imaging Contrast Agent Targeting Prostate Cancer
by: Hang Xu, et al.
Published: (2024-07-01)